T Cell Lymphomas
Conference Coverage
Severe psoriasis upped lymphoma risk in large cohort study
SCOTTSDALE, ARIZ. – Psoriasis of all severities was linked to a 3.5-fold increase in risk of cutaneous T-cell lymphoma, and severe psoriasis upped...
Conference Coverage
Mogamulizumab achieves objective responses in relapsed/refractory adult T-cell leukemia-lymphoma
Key clinical point: The anti-CCR4 monoclonal antibody mogamulizumab was superior to other investigator-selected therapies for the treatment of...
Conference Coverage
Alemtuzumab plus CHOP didn’t boost survival in elderly patients with peripheral T-cell lymphomas
Key clinical point: Adding the monoclonal anti-CD52 antibody alemtuzumab to CHOP (A-CHOP) increased response rates in elderly patients with...
Conference Coverage
Dr. Matt Kalaycio’s top 10 hematologic oncology abstracts for ASCO 2016
News
Peripheral T-cell lymphoma incidence and survival varies significantly by race
Key clinical point: Peripheral T-cell lymphoma incidence, proportions of subtypes, and survival differed markedly among racial/ethnic...
News
Antilymphocyte globulin curbs chronic graft-versus-host disease
Key clinical point: Chronic graft-versus-host disease (GVHD) after allogeneic stem cell transplantation with peripheral blood stem cells was less...
Commentary
Medical Roundtable: Peripheral T-Cell Lymphomas: A Practical Approach to Newly Diagnosed and Relapsed Patients
Conference Coverage
ACR: Years of TNF blockers did not increase risk of lymphoma in RA
Exposure to biological disease-modifying antirheumatic drugs did not increase the overall risk of lymphoma among patients with rheumatoid...
Conference Coverage
What’s on tap at ASH 2015
News
Topical resiquimod effective for early-stage cutaneous T-cell lymphoma
Key clinical point: Topical resiquimod was effective and well tolerated in patients with early-stage cutaneous T-cell lymphoma (CTCL).